Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 known ✓ | O15379 | 4/20 | 0.46 |
| ▸ | HDAC1 known ✓ | Q13547 | 4/20 | 0.46 |
| ▸ | HDAC2 known ✓ | Q92769 | 4/20 | 0.46 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 4/20 | 0.46 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.35 |
| ▸ | PPARG known ✓ | P37231 | 2/20 | 0.33 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | TET2 | Q6N021 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TET3 | O43151 | 1/20 | 0.36 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6910298 | 1.00 | HDAC3 (0.46) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Hydrochloric Acid SCHEMBL2564981 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL534131 | 0.97 | — | — | |
| SCHEMBL17818 | 0.95 | — | — | |
| Methylamine SCHEMBL5983832 | 0.92 | HDAC3 (0.43) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| Ethylene SCHEMBL5835732 | 0.92 | HDAC3 (0.48) | HDAC3HDAC1HDAC2HDAC8FFAR3 | |
| SCHEMBL29143554 | 0.92 | — | — | |
| SCHEMBL20262532 | 0.92 | — | — | |
| Bromide SCHEMBL4851394 | 0.92 | — | — | |
| Water SCHEMBL11376127 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5712356-A | Cross-linkable copolymers and hydrogels | CIBA VISION CORPORATION (US) | 1998-01-27 | — | — | US | claimed |
| EP-2695003-B1 | COMPOSITION FOR FORMING A CONTACT LENS | NOVARTIS AG (CH) | 2015-03-18 | — | — | EP | disclosed |
| EP-2695003-A1 | COMPOSITION FOR FORMING A CONTACT LENS | Novartis AG (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-8618187-B2 | Composition for forming a contact lens | NOVARTIS AG (CH) | 2013-12-31 | — | — | US | disclosed |
| US-20120252921-A1 | COMPOSITION FOR FORMING A CONTACT LENS | ALCON INC. (CH) | 2012-10-04 | — | — | US | disclosed |
| WO-2012130956-A1 | COMPOSITION FOR FORMING A CONTACT LENS | NOVARTIS AG (CH) | 2012-10-04 | — | — | WO | disclosed |
| WO-2010060958-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING O-DESMETHYL-VENLAFAXINE | LEK PHARMACEUTICALS D.D. (SI) | 2010-06-03 | — | — | WO | disclosed |
| EP-1044390-B1 | PROGRAMMABLE CORRECTIVE LENS | NOVARTIS AG (CH) | 2004-06-30 | — | — | EP | disclosed |
| EP-0788505-B1 | POLY-UNSATURATED CARBOHYDRATE DERIVATIVES, POLYMERS THEREOF AND THEIR USE | NOVARTIS AG (CH) | 2002-06-12 | — | — | EP | disclosed |
| US-6342570-B1 | COPOLYMERIZING VINYL LACTAM AND VINYL MONOMER; METERING IN SECOND MONOMER MIXTURE; STATISTICALLY DISTRIBUTED BUILDING BLOCKS IN ACCORD WITH LEWIS-MAYO EQUATION; CURABLE | NOVARTIS AG (CH) | 2002-01-29 | — | — | US | disclosed |
| EP-0800541-B1 | SILOXANE-CONTAINING NETWORKS | NOVARTIS AG (CH) | 1999-02-24 | — | — | EP | disclosed |
| US-5856416-A | CROSSLINKING | CIBA VISION CORPORATION (US) | 1999-01-05 | — | — | US | disclosed |
| US-5712356-A | Cross-linkable copolymers and hydrogels | CIBA VISION CORPORATION (US) | 1998-01-27 | — | — | US | disclosed |
| US-5693768-A | REACTING WITH AN UNSATURATED ISOCYANATE OR AMINE COMPOUND | CIBA VISION CORPORATION (US) | 1997-12-02 | — | — | US | disclosed |
| EP-0800541-A1 | SILOXANE-CONTAINING NETWORKS | Novartis AG (CH) | 1997-10-15 | — | — | EP | disclosed |
| EP-0788505-A1 | POLY-UNSATURATED CARBOHYDRATE DERIVATIVES, POLYMERS THEREOF AND THEIR USE | Novartis AG (CH) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996020964-A1 | SILOXANE-CONTAINING NETWORKS | NOVARTIS AG (CH) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996013511-A1 | POLY-UNSATURATED CARBOHYDRATE DERIVATIVES, POLYMERS THEREOF AND THEIR USE | NOVARTIS AG (CH) | 1996-05-09 | — | — | WO | disclosed |
| EP-0668294-A1 | Unsaturated carbohydrate derivatives, polymers therefrom and their application | CIBA-GEIGY AG (CH) | 1995-08-23 | — | — | EP | disclosed |
| EP-0655470-A1 | Cross-linkable copolymers and hydrogels | CIBA-GEIGY AG (CH) | 1995-05-31 | — | — | EP | disclosed |